Newsweek is reporting on the evolving landscape of U.S. politics, asserting that the political environment has fundamentally changed since the 2016 election. It said traditional approaches, such as those advocated by figures like David Axelrod, are no longer effective. Newsweek highlighted the Jon Ossoff-Natalie Harp story as an example of a more aggressive, "offense-oriented" political strategy that it believes is necessary for future electoral success, particularly for Democrats. The publication argued that clinging to a "moral high ground" will lead to continued losses and that parties must adapt to a more combative political style.
Newsweek also reported a significant breakthrough in cancer research, noting that Moderna and Merck announced successful late-stage trial results for their personalized mRNA therapy in melanoma patients. It said this marks the first time mRNA technology, developed and scaled during the COVID-19 pandemic, has succeeded in a large oncological trial, potentially allowing high-risk cancer patients to live longer without recurrence. Newsweek suggested this could usher in a "golden age" of personalized cancer therapies, making the disease more manageable. The publication criticized anti-vaccine sentiment in light of these developments, pointing out the irony that President Donald J Trump's Operation Warp Speed facilitated the vaccine technology, while his administration, under a different HHS, is reportedly terminating mRNA research contracts.
Additionally, Newsweek noted that the national debt has surpassed $40 trillion.